Dermocosmetic or pharmaceutical use of a composition comprising at least one inhibitor of some chemoattractant cytokines
AssigneesGreenpharma, Centre National de la Recherche Scientifique (CNRS), Universite De Strasbourg
InventorsPhilippe Bernard, Dayana Abboud, Jean-Luc Galzi, Nelly Frossard, Christelle Pillard, Quoc Tuan Do
Life of this patent
Estimating the term…
Abstract
The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.
Claims13
A method for treating internal or external chronic inflammatory diseases in a human or animal individual, comprising administering to the individual a cosmetic or pharmaceutical composition comprising, in an acceptable vehicle, an effective amount of 3,7-dihydro-1,3-dimethyl-7-(3-methyl-2-butenyl)-1H-purin-2,6-dione or an addition salt thereof, as active agent, and wherein the diseases are chronic inflammatory diseases selected from the group consisting of atopic dermatitis, psoriasis, dry skin with atopic tendencies, Crohn's disease and allergic asthma.
Dependencies are inferred from the claim text.